Astera Labs (NASDAQ:ALAB) Stock Price Down 2.6% – Time to Sell?

Shares of Astera Labs, Inc. (NASDAQ:ALAB) dropped 2.6% during trading on Monday . The stock traded as low as $266.31 and last traded at $277.53. 3,390,644 shares were traded during mid-day trading, a decline of 38% from the average daily volume of 5,441,372 shares. The stock had previously closed at $284.97.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the stock. Needham & Company LLC upped their price target on shares of Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Citigroup reissued a “buy” rating on shares of Astera Labs in a research note on Wednesday, July 29th. Rothschild & Co Redburn assumed coverage on shares of Astera Labs in a research report on Friday, May 1st. They set a “neutral” rating and a $153.00 price objective for the company. Zacks Research upgraded Astera Labs from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. Finally, Barclays raised their target price on Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a report on Monday, July 20th. One analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and eight have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Astera Labs presently has an average rating of “Moderate Buy” and a consensus target price of $333.00.

Astera Labs Stock Performance

The firm’s fifty day moving average is $352.70 and its 200-day moving average is $245.57. The company has a market capitalization of $48.15 billion, a P/E ratio of 137.39 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. During the same quarter in the prior year, the firm earned $0.44 EPS. The firm’s revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, analysts expect that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Insider Activity at Astera Labs

In related news, Director Jack R. Lazar sold 10,000 shares of the firm’s stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the sale, the director owned 75,688 shares of the company’s stock, valued at $26,882,106.96. This trade represents a 11.67% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of the business’s stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $450.00, for a total value of $4,047,300.00. Following the sale, the director owned 4,631 shares in the company, valued at $2,083,950. This represents a 66.01% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 419,244 shares of company stock valued at $163,135,169. 10.40% of the stock is owned by company insiders.

Institutional Trading of Astera Labs

A number of hedge funds have recently made changes to their positions in ALAB. California State Teachers Retirement System grew its holdings in shares of Astera Labs by 49,273.2% during the second quarter. California State Teachers Retirement System now owns 100,158,544 shares of the company’s stock worth $48,378,580,000 after purchasing an additional 99,955,684 shares during the last quarter. Vanguard Group Inc. raised its holdings in Astera Labs by 0.6% in the 4th quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock valued at $2,300,344,000 after buying an additional 84,365 shares during the last quarter. BlackRock Inc. bought a new position in Astera Labs in the 2nd quarter valued at approximately $6,609,581,000. Atreides Management LP boosted its position in Astera Labs by 108.9% during the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after buying an additional 1,754,593 shares during the period. Finally, State Street Corp boosted its position in Astera Labs by 32.5% during the 4th quarter. State Street Corp now owns 3,099,809 shares of the company’s stock worth $515,684,000 after buying an additional 760,358 shares during the period. 60.47% of the stock is owned by institutional investors and hedge funds.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.